Cerebrospinal Fluid Proteomic Profiling of HIV-1-Infected Patients with Cognitive Impairment
Authors:
Open Access
- 12 October 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 6 (11) , 4189-4199
Abstract
Advanced HIV-1 infection is commonly associated with progressive immune suppression and the development of cognitive, motor, and behavior disturbances. In its most severe form, it is diagnosed as HIV-1 associated dementia (HAD) and can progress to profound functional disability and death. Despite prodigious efforts to uncover biomarkers of HAD, none can adequately reflect disease onset or progression. Thus, we developed a proteomics platform for HAD biomarker discovery and used it to perform a pilot study on cerebrospinal fluid (CSF) from HIV-1-infected people with or without HAD. A 2-dimensional electrophoresis (2-DE) map of a HAD CSF proteome was focused on differentially expressed proteins. 2-DE difference gel electrophoresis (2-D DIGE) analysis showed >90 differences in protein spots of which 20 proteins were identified. Differential expression of 6 proteins was validated by Western blot tests and included vitamin D binding protein, clusterin, gelsolin, complement C3, procollagen C−endopeptidase enhancer 1, and cystatin C. We posit that these proteins, alone or together, are potential HAD biomarkers. Keywords: proteomics • 2-dimensional electrophoresis • DIGE • cerebrospinal fluid • HIV • cognitive impairment • HADKeywords
This publication has 39 references indexed in Scilit:
- Investigating the human immunodeficiency virus type 1-infected monocyte-derived macrophage secretomeVirology, 2007
- Associative and predictive biomarkers of dementia in HIV-1–infected patientsNeurology, 2007
- Proteomics in neurosciencesMass Spectrometry Reviews, 2007
- Is the Glass Three‐Quarters Full or One‐Quarter Empty?The Journal of Infectious Diseases, 2006
- Disease Biomarkers in Cerebrospinal Fluid of Patients with First-Onset PsychosisPLOS Medicine, 2006
- Complement C3c and related protein biomarkers in amyotrophic lateral sclerosis and Parkinson’s diseaseBiochemical and Biophysical Research Communications, 2006
- Shedding of PECAM-1 during HIV infection: a potential role for soluble PECAM-1 in the pathogenesis of NeuroAIDSJournal of Leukocyte Biology, 2005
- Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virusVirus Research, 2005
- Cystatin C as a potential cerebrospinal fluid marker for the diagnosis of Creutzfeldt‐Jakob diseaseProteomics, 2004
- Microglia in human immunodeficiency virus‐associated neurodegenerationGlia, 2002